AF and his relevancy to PLI if any.
First let me go on the record. I think he is in the pocket of some large venture funds who are shorting the biotech market, especially the small cap biotechs that they think are easy pickings at this early stage of their corporate growth. He has spoken against many - some of which I have a significant position, such as NWBO, CUR, AGEN, and others. I obviously disagree with him on many of these but he is nevertheless quite influential and sometimes right. as most of the early biotech eventually fail, the odds are in favor of the nay sayers. But he will twist the truth as he has done most famously with NWBO. He also hit GALE, GALT and many others.
Notwithstanding the above I think there is a very interesting tweet that AF posted on the topic of a NASH release. This is obviously the connection here to PLI and 4050. He claims that Galt paid for misleading PR in connection to NASH research. Here are three of his tweets: